Advertisement

Ranbaxy Laboratories Limited Company Profile

14:35 EDT 19th May 2013 | BioPortfolio

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. It is ranked amongst the top ten generic companies worldwide. The Company has manufacturing operations in 8 countries with a ground presence in 49 countries and its products are available in over 125 countries.
Ranbaxy was incorporated in 1961 and went public in 1973. For the twelve months ended December 31, 2005, the Company's Global Sales were at US $1178 Mn. Overseas markets accounted for 76% of global sales. The Company's largest market USA with the sales of US $ 328 Mn, accounted for 28%, while Europe and BRIC (Brazil, Russia, India, China) countries contributed 17% and 29% to global sales.

Location

Plot 90, Sector 32,
Gurgaon
Haryana
122001
India

Contact

Phone: 91-124-4135000
Fax: 91-124-4135001
Email: ramesh.adige@ranbaxy.com


News Articles [ 499 Associated News Articles listed on BioPortfolio]

Ranbaxy Launches Absorica' (Isotretinoin) Capsules In The U.S. Healthcare Market

PRINCETON, N.J., Nov.26, 2012 /PRNewswire/ --Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Ab...

BRIEF-Ranbaxy pleads guilty to felony charges over drugs, to pay $500 mln in U.S. settlement

May 13 (Reuters) - Ranbaxy Laboratories Ltd : * U.S. Justice Department says Ranbaxy Laboratories Ltd unit pleads

Ranbaxy Launches Absoricatm (Isotretinoin) Capsules in the U.S. Healthcare Market

Gurgaon, India, November 26, 2012 Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Absorica (Isotret...

Ranbaxy Launches Absorica (Isotretinoin) Capsules in the U.S.

Ranbaxy Laboratories, Inc. (RLI), a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), today announced the sales and promotion launch of Absorica (Isotretinoin) Capsules, a product that is...

More downs than ups for Ranbaxy

A further problem with Indian generics manufacturer Ranbaxy Laboratories (Ranbaxy) could affect its reputation yet again with US FDA. This time, Ranbaxy fell foul of an Indian state regulator, the Mah...

Ranbaxy CEO planning expansion in US, elsewhere

PLAINSBORO TOWNSHIP, N.J. (AP) — The head of Indian drugmaker Ranbaxy Laboratories Ltd. says he's charging ahead with plans to expand sales in the crucial U.S. market, despite extra oversight from A...

Ranbaxy Laboratories launches anti-acne drug in US

Research based pharmaceutical company Ranbaxy Laboratories has launched Absorica (Isotretinoin) Capsules, designed to treat severe recalcitrant nodular acne, in the US.

Daiichi Sankyo To Use Venezuela Presence To Market Ranbaxy Generics

Daiichi Sankyo and its Ranbaxy Laboratories unit have decided to do their own distribution of Ranbaxy generics in Venezuela, using what they called a "hybrid business model."

Drugs and Medications [ 431 Associated Drugs and Medications listed on BioPortfolio]

Desquam-x wash [Ranbaxy Laboratories Inc.]

DRUG FACTS

Famotidine [Ipca Laboratories Limited]

Famotidine Tablets USP

Cetirizine hydrochloride [Ipca Laboratories Limited]

Cetirizine Hydrochloride Tablets 10 mg

Clindamycin hydrochloride [RedPharm Drug Inc.]

Eurax [Ranbaxy Laboratories Inc.]

Eurax (crotamiton USP)Lotion/Cream (10% w/w)FOR TOPICAL USE ONLYNOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USERx only

PubMed Articles [ 108 Associated PubMed Articles listed on BioPortfolio]

Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.

A novel set of compounds with a 1,3-dioxolane ring which acts as a proline bioisostere have been successfully designed as VLA-4 receptor antagonists. Compounds (18e), (28j), and (35g) were shown to ha...

Synthesis and in vitro activity of novel 1,2,4-triazolo4,3-apyrimidine oxazolidinone antibacterial agents.

The synthesis and antibacterial activity of 3-(4-([1,2,4]triazolo[4,3-a]pyrimidin-3-yl)phenyl)oxazolidin-2-ones is reported. Thiocarbonyl derivatives were found to be potent inhibitors of Gram-positiv...

Controlled ex-vivo plasma hydrolysis of valaciclovir to acyclovir demonstration using tandem mass spectrometry.

Plasma estimation of valaciclovir, an antiviral drug, is challenging due to both in-vivo and ex-vivo hydrolysis to active metabolite acyclovir. A simultaneous method is described involving the solid-p...

Stability-indicating validation of acitretin and isoacitretin in human plasma by LC-ESI-MS/MS bioanalytical method and its application to pharmacokinetic analysis.

LC- ESI- MS/MS simultaneous bioanalytical method was developed to determine acitretin and its metabolite isoacitretin in human plasma using acitretin-d3 used as the internal standard for both analytes...

Inaccurate Reporting of Mineral Composition by Commercial Stone Analysis Laboratories: Implications for Infection and Metabolic Stones.

PURPOSE: We determined the accuracy of stone composition analysis at commercial laboratories. MATERIALS AND METHODS: A total of 25 human renal stones with infrared spectroscopy determined composition...

Clinical Trials [ 177 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

To compare the single-dose oral bioavailability of clarithromycin 250-mg/5 mL powder for oral suspension of Ranbaxy Laboratories with that of Abbott Laboratories (Biaxin®) following admin...

Bioequivalence Study of Quinapril Hydrochloride 20 mg and Hydrochlorothiazide 25 mg Tablets Under Fed Conditions

This open-label, balanced, randomized, two-treatment, four-period, two-sequence, single dose, crossover fully replicated study was conducted on fixed-dose combination of quinapril 20 mg an...

Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fed Conditions

The objective of this study was to compare the single-dose oral bioavailability of Carvedilol 12.5 mg tablets of Ranbaxy Laboratories with Coreg 12.5 mg tablets of Glaxosmithkline in healt...

Bioequivalence Study of Glimepiride 1mg Tablets Under Fed Conditions

The objective of this study is to compare the relative bioavailability of glimepiride 1 mg tablets (manufactured by Ranbaxy Laboratories Limited) with that of AMARYL® 1 mg tablets (follow...

Bioequivalence Study of Hydrochlorothiazide 50mg Tablets Under Fasting Conditions

To compare the single-dose oral bioavailability of hydrochlorothiazide 50 mg tablet of Ohm Laboratories (A subsidiary of Ranbaxy pharmaceuticals USA) with hydrochlorothiazide 50 mg tablet...

Companies [ 818 Associated Companies listed on BioPortfolio]

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India’s largest pharmaceutical comp...

Ranbaxy Laboratories Ltd.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, aff...

Ranbaxy Laboratories Limited

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company, producing a wide range of quality,...

Sterling Rasayan (P) Ltd

In less than twenty years, Sterling through its professional approach and innovative marketing strategy has been able to cater to the requirements of many prestigious customers from local producers t...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

More Information about "Ranbaxy Laboratories Limited" on BioPortfolio

We have published hundreds of Ranbaxy Laboratories Limited news stories on BioPortfolio along with dozens of Ranbaxy Laboratories Limited Clinical Trials and PubMed Articles about Ranbaxy Laboratories Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ranbaxy Laboratories Limited Companies in our database. You can also find out about relevant Ranbaxy Laboratories Limited Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement